Aphria (APHA) stock is down after two independent advisory firms recommended that shareholders of Aphria stock vote for the merger between Aphria and Tilray (TLRY), in which Tilray would acquire all of Aphria's outstanding shares. Shares of APHA were down 0.5%, and shares of TLRY were down 1.75% as of 11:54 am on Monday.
Full Answer
Should you hold Aphria (APHA) stock?
The consensus among Wall Street equities research analysts is that investors should "hold" Aphria stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in APHA, but not buy additional shares or sell existing shares. View analyst ratings for Aphria or view top-rated stocks.
How can I get the latest news about APHA?
Sign up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
How badly did Aphria (APH) Whiff on revenue?
While the company posted a net loss per share for the quarter that was modestly narrower than expected ($0.02 versus $0.03), Aphria whiffed badly on revenue for the quarter. First-quarter revenue, in fact, came in 8.7% lower than FactSet's consensus estimate for the three-month period.
Will APHA outperform or underperform the S&P 500 over the long term?
Vote “Outperform” if you believe APHA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe APHA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Why did Aphria stock drop today?
Aphria stock plunged Monday after the Canadian cannabis firm missed expectations for third-quarter sales and its net loss widened. Also falling were shares of Canadian peer Tilray , which plans to merge with Aphria.
What is the forecast for APHA stock?
Aphria Inc quote is equal to 17.230 USD at 2022-06-07. Based on our forecasts, a long-term increase is expected, the "APHA" stock price prognosis for 2026-07-01 is 58.128 USD. With a 5-year investment, the revenue is expected to be around +237.36%. Your current $100 investment may be up to $337.36 in 2027.
Is APHA a buy or sell?
Enterprise Value (EV) is Market Capitalization + Debt - Cash....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy25.08%2Buy18.56%3Hold10.15%4Sell5.79%2 more rows
Should I sell my Aphria stocks?
Aphria Inc(APHA-T) Rating Stockchase rating for Aphria Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.
How can I buy APHA stock?
How to Buy Aphria Inc. (APHA) StockPick a brokerage. Your first step is to choose a brokerage to host your account. ... Decide how many shares you want. How much do you want to invest in Aphria? ... Choose your order type. ... Execute your trade.
What happens to Aphria stock after merger?
What will happen to Aphria once the arrangement is completed? Once completed, Tilray will acquire all outstanding Aphria Shares and Aphria will become a wholly-owned subsidiary of Tilray. Aphria Shares will be delisted from the TSX and NASDAQ.
What happened to APHA?
Aphria's (APHA) last trading day is today after it complete its deal with Tilray (NASDAQ:TLRY).
Will Tilray go public?
In December 2020, the company announced a merger with Aphria, and will operate under the Tilray name and its ticker symbol on NASDAQ and the Toronto Stock Exchange....TypePublicNumber of employees1,030 (2020)WebsiteTilray.com6 more rows
Is Tilray buying Aphria?
After Tilray's (TLRY) shareholders voted in favor of the proposed merger Aphria (APHA) last Friday, the two cannabis companies announced today the completion of the transaction.
Will Aphria stock become Tilray?
Aphria to lose its name and independent stock symbol Wednesday. Tilray Inc. and Aphria Inc. say their merger deal has now closed after receiving approval from shareholders of both companies.
Is Tilray merger with Aphria?
Once-rival cannabis producers Tilray and Aphria completed their megamerger, the new company announced Monday, forming one of the biggest diversified marijuana, hemp and beer companies in the world.
How were Aphria's earnings last quarter?
Aphria Inc. (NASDAQ:APHA) released its earnings results on Sunday, April, 11th. The company reported ($1.14) earnings per share (EPS) for the quart...
Who are Aphria's key executives?
Aphria's management team includes the following people: Mr. Irwin D. Simon , CEO & Chairman (Age 62, Pay $5.23M) Mr. Carl A. Merton , Chief Fin...
Who are some of Aphria's key competitors?
Some companies that are related to Aphria include STADA Arzneimittel Aktiengesellschaft (STDAF) , Tilray (TLRY) , Canopy Growth (CGC) , USANA H...
What other stocks do shareholders of Aphria own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV) , Alibaba Grou...
What is Aphria's stock symbol?
Aphria trades on the NASDAQ under the ticker symbol "APHA."
What is Aphria's stock price today?
One share of APHA stock can currently be purchased for approximately $15.38.
How much money does Aphria make?
Aphria (NASDAQ:APHA) has a market capitalization of $4.87 billion and generates $405.96 million in revenue each year. The company earns $-63.21 mil...
How many employees does Aphria have?
Aphria employs 1,200 workers across the globe.
What is Aphria's official website?
The official website for Aphria is aphriainc.com .
Who is the CEO of Aphria?
It's also true that Aphria Chairman and CEO Vic Neufeld was once chairman of Scythian Biosciences. The report also seems to make a pretty good case that Aphria overpaid for these acquisitions. What remains only conjecture at this point, however, is whether there were any company insiders who benefited from the deals.
Who is the hedge fund manager for Aphria?
This huge drop came after hedge fund manager Gabriel Grego announced a short position in Aphria and referred to the Canadian marijuana producer as "a black hole" for investors' money.
Did Aphria respond to Grego's allegations?
As of the time of this writing, Aphria had not responded publicly to the allegations made by Grego. It's always good to hear both sides of a story before reaching any conclusions. However, the report issued by Quintessential Capital Management and Hindenburg Research is concerning.
What happened
Shares of the Canadian pot giant Aphria ( APHA ) are under serious pressure today. The company's stock was down by a whopping 13.4% as of 9:37 a.m. EDT Thursday morning.
So what
Aphria's brain trust placed the blame for this quarterly revenue miss squarely on the coronavirus pandemic.
NASDAQ: APHA
Unfortunately, it's not altogether clear when Aphria's distribution revenue will get back on track. The COVID-19 pandemic is still slowing down in-person visits to doctors' offices and pharmacies across the globe. In other words, investors probably shouldn't expect this key area of Aphria's business to rebound anytime soon.
Now what
Is Aphria's stock a bad-news buy? Like almost all marijuana companies, Aphria is facing an extremely challenging operating environment at the moment. As such, it might be a good idea to watch this small-cap cannabis stock from the safety of the sidelines for the time being.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
There appears to be a lack of professional enthusiasm for the stock following the company's big announcement
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
What happened
Marijuana stock Aphria ( NASDAQ:APHA) declined notably on Monday, shedding almost 5.8% of its value. While investors have already digested last week's news of the company's merger with peer Canadian weedie Tilray ( NASDAQ:TLRY), other factors might be affecting sentiment on the stock.
So what
As is usually the case in notable mergers, several prognosticators tracking Aphria (and Tilray, while we're at it) revised their analyses. It seems that the ones getting more bearish on Aphria are catching the ears of investors.
Now what
Since marijuana stocks keep getting blasted with bad news, investors are probably looking for much more enthusiastic recommendations to support their investment. Given that the Aphria bulls are really only adding a dollar or several at best to their price targets after the merger announcement, those recommendations don't seem to be forthcoming.